M.F. Mosele

Abstract PD8-02: Trastuzumab deruxtecan (T-DXd) for advanced breast cancer patients (ABC), regardless HER2 status: A phase II study with biomarkers analysis (DAISY)

Véronique Dièras, Élise Deluche, Amélie Lusque et al. · Cancer Research · 2022 · 107 citations

Abstract Pd8-02, Breast Oncology, Immunology +27

LBA1 Unraveling the mechanism of action and resistance to trastuzumab deruxtecan (T-DXd): Biomarker analyses from patients from DAISY trial

M.F. Mosele, Amélie Lusque, Véronique Dièras et al. · Annals of Oncology · 2022 · 48 citations

Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors

Mihaela Aldea, Marco Tagliamento, Arnaud Bayle et al. · JCO Precision Oncology · 2023 · 19 citations

189O A phase II study of patritumab deruxtecan (HER3-DXd), in patients (pts) with advanced breast cancer (ABC), with biomarker analysis to characterize response to therapy (ICARUS-BREAST01)

B. Pistilli, Nusaïbah Ibrahimi, M. Lacroix-Triki et al. · ESMO Open · 2023 · 17 citations · Full text

Breast Oncology, Immunology, Pathology +16